Assoc. Prof. Phạm Thị Ngọc Thảo, deputy director of the hospital, speaks at Chợ Rẫy Hospital’s first Subclinical Scientific Symposium on December 17. VNA/VNS Photo

HCM CITY — The application of artificial intelligence (AI) and technical advances in subclinical diagnosis and treatment were presented at Chợ Rẫy Hospital’s first Subclinical Scientific Symposium that opened on December 17 in HCM City.

The two-day event themed “Application of artificial intelligence and new techniques in diagnosis and treatment” featured discussions on nearly 40 topics related to cutting edge techniques of subclinical diagnosis and treatment.

Topics under discussion included application of AI in blood cell image analysis and pathology diagnostic, next-generation sequencing applications based on the ionic semiconductor technology, technical advances in endovascular intervention in the treatment of cerebral aneurysms, automatic 3D breast ultrasound, and automation in laboratory operation and management.

The application of AI in pathology diagnostic support will improve the accuracy of diagnostics, according to Dr. Hoàng Văn Thịnh, head of the hospital’s Department of Pathology.

Chợ Rẫy Hospital has pioneered digital pathology in the country, he said.

Next-generation sequencing applications based on ionic semiconductor technology is one of technical advances adopted at Chợ Rẫy hospital.

The next-generation sequencing is becoming more popular due to its effectiveness in multi-target gene diagnosis in only one reaction, helping to shorten the time of diagnosis and save costs for patients, according to doctors.

Assoc. Prof. Phạm Thị Ngọc Thảo, deputy director of the hospital, said hospitals in Việt Nam have been increasingly applying many cutting edge techniques in the world, particularly technical advances in subclinical diagnosis.

The symposium served as a platform for doctors at subclinical departments to share new techniques and achievements that help achieve the best treatment outcomes for patients, Thảo said. —VNS